Harnessing Unique Boron Chemistry to Develop a New Class of Non-hydroxamate HDAC Inhibitors with Validated In Vivo Efficacy.
- DOI
- 10.1021/acs.jmedchem.5c03600
- Published
- 2026 Mar 12
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.5c03600,
title = {Harnessing Unique Boron Chemistry to Develop a New Class of Non-hydroxamate HDAC Inhibitors with Validated In Vivo Efficacy.},
author = {Zhou LY and Li YL and Zhang JD and Zhang XY and He ML and Shi T and Chen ZQ and Xiao YC and Chen FE},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.5c03600},
url = {https://doi.org/10.1021/acs.jmedchem.5c03600}
}RIS
TY - JOUR TI - Harnessing Unique Boron Chemistry to Develop a New Class of Non-hydroxamate HDAC Inhibitors with Validated In Vivo Efficacy. AU - Zhou LY AU - Li YL AU - Zhang JD AU - Zhang XY AU - He ML AU - Shi T AU - Chen ZQ AU - Xiao YC AU - Chen FE PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.5c03600 UR - https://doi.org/10.1021/acs.jmedchem.5c03600 ER -
APA
LY, Z., YL, L., JD, Z., XY, Z., ML, H., T, S., ZQ, C., YC, X., & FE, C. (2026). Harnessing Unique Boron Chemistry to Develop a New Class of Non-hydroxamate HDAC Inhibitors with Validated In Vivo Efficacy.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.5c03600
Source records
- pubmed · retrieved 2026-09-26T06:18:34.786Z